Literature DB >> 25547714

Adult AMPA GLUA1 receptor subunit loss in 5-HT neurons results in a specific anxiety-phenotype with evidence for dysregulation of 5-HT neuronal activity.

Tillmann Weber1, Miriam A Vogt2, Sarah E Gartside3, Stefan M Berger4, Rafael Lujan5, Thorsten Lau6, Elke Herrmann4, Rolf Sprengel7, Dusan Bartsch4, Peter Gass2.   

Abstract

Both the glutamatergic and serotonergic (5-HT) systems are implicated in the modulation of mood and anxiety. Descending cortical glutamatergic neurons regulate 5-HT neuronal activity in the midbrain raphe nuclei through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors. To analyze the functional role of GLUA1-containing AMPA receptors in serotonergic neurons, we used the Cre-ERT2/loxP-system for the conditional inactivation of the GLUA1-encoding Gria1 gene selectively in 5-HT neurons of adult mice. These Gria1(5-HT-/-) mice exhibited a distinct anxiety phenotype but showed no alterations in locomotion, depression-like behavior, or learning and memory. Increased anxiety-related behavior was associated with significant decreases in tryptophan hydroxylase 2 (TPH2) expression and activity, and subsequent reductions in tissue levels of 5-HT, its metabolite 5-hydroxyindoleacetic acid (5-HIAA), and norepinephrine in the raphe nuclei. However, TPH2 expression and activity as well as monoamine levels were unchanged in the projection areas of 5-HT neurons. Extracellular electrophysiological recordings of 5-HT neurons revealed that, while α1-adrenoceptor-mediated excitation was unchanged, excitatory responses to AMPA were enhanced and the 5-HT1A autoreceptor-mediated inhibitory response to 5-HT was attenuated in Gria1(5-HT-/-) mice. Our data show that a loss of GLUA1 protein in 5-HT neurons enhances AMPA receptor function and leads to multiple local molecular and neurochemical changes in the raphe nuclei that dysregulate 5-HT neuronal activity and induce anxiety-like behavior.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547714      PMCID: PMC4397405          DOI: 10.1038/npp.2014.332

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  70 in total

1.  The use of behavioral test batteries: effects of training history.

Authors:  K L McIlwain; M Y Merriweather; L A Yuva-Paylor; R Paylor
Journal:  Physiol Behav       Date:  2001-08

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Learned helplessness: validity and reliability of depressive-like states in mice.

Authors:  S Chourbaji; C Zacher; C Sanchis-Segura; C Dormann; B Vollmayr; P Gass
Journal:  Brain Res Brain Res Protoc       Date:  2005-11-23

4.  The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.

Authors:  G M Goodwin; R J De Souza; A R Green
Journal:  Neuropharmacology       Date:  1985-12       Impact factor: 5.250

5.  Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat.

Authors:  E S Levine; B L Jacobs
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

6.  Memory retrieval after contextual fear conditioning induces c-Fos and JunB expression in CA1 hippocampus.

Authors:  T Strekalova; B Zörner; C Zacher; G Sadovska; T Herdegen; P Gass
Journal:  Genes Brain Behav       Date:  2003-02       Impact factor: 3.449

Review 7.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

8.  A molecular basis of analgesic tolerance to cannabinoids.

Authors:  Anke Tappe-Theodor; Nitin Agarwal; István Katona; Tiziana Rubino; Lene Martini; Jakub Swiercz; Ken Mackie; Hannah Monyer; Daniela Parolaro; Jennifer Whistler; Thomas Kuner; Rohini Kuner
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

9.  Inducible gene manipulations in serotonergic neurons.

Authors:  Tillmann Weber; Gerald Böhm; Elke Hermann; Günther Schütz; Kai Schönig; Dusan Bartsch
Journal:  Front Mol Neurosci       Date:  2009-11-06       Impact factor: 5.639

10.  Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification.

Authors:  Lise Gutknecht; Naozumi Araragi; Sören Merker; Jonas Waider; Frank M J Sommerlandt; Boris Mlinar; Gilda Baccini; Ute Mayer; Florian Proft; Michel Hamon; Angelika G Schmitt; Renato Corradetti; Laurence Lanfumey; Klaus-Peter Lesch
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more
  8 in total

Review 1.  Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Authors:  Charlene Faye; Josephine C Mcgowan; Christine A Denny; Denis J David
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

2.  Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target.

Authors:  Gabor Egervari; Joseph Landry; James Callens; John F Fullard; Panos Roussos; Eva Keller; Yasmin L Hurd
Journal:  Biol Psychiatry       Date:  2016-09-28       Impact factor: 13.382

3.  Study of analgesic effect of earthworm extract.

Authors:  Wei Luo; Zhen-Han Deng; Rui Li; Guo Cheng; Ronak Naveenchandra Kotian; Yu-Sheng Li; Wen-Ping Li
Journal:  Biosci Rep       Date:  2018-01-25       Impact factor: 3.840

4.  MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ25-35 -induced anxiety and cognitive deficits in a mouse model.

Authors:  Hei-Jen Huang; Hsin-Yu Huang; Hsiu Mei Hsieh-Li
Journal:  CNS Neurosci Ther       Date:  2018-07-05       Impact factor: 5.243

5.  Fetal glucocorticoid receptor (Nr3c1) deficiency alters the landscape of DNA methylation of murine placenta in a sex-dependent manner and is associated to anxiety-like behavior in adulthood.

Authors:  Michaela Schmidt; Elad Lax; Rudy Zhou; David Cheishvili; Arne Mathias Ruder; Alessia Ludiro; Florian Lapert; Anna Macedo da Cruz; Paolo Sandrini; Teresa Calzoni; Farida Vaisheva; Christiane Brandwein; Alessia Luoni; Renaud Massart; Laurence Lanfumey; Marco Andrea Riva; Michael Deuschle; Peter Gass; Moshe Szyf
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

Review 6.  Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders.

Authors:  Dan Li; Shuang Yu; Yu Long; Ai Shi; Jie Deng; Yin Ma; Jing Wen; Xiaoqiu Li; Songyu Liu; Yulu Zhang; Jinyan Wan; Nan Li; Rui Ao
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 7.  Serotonin, neural markers, and memory.

Authors:  Alfredo Meneses
Journal:  Front Pharmacol       Date:  2015-07-21       Impact factor: 5.810

8.  Generalized and social anxiety disorder interactomes show distinctive overlaps with striosome and matrix interactomes.

Authors:  Kalyani B Karunakaran; Satoko Amemori; N Balakrishnan; Madhavi K Ganapathiraju; Ken-Ichi Amemori
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.